跳至主要内容
临床试验/CTRI/2019/04/018702
CTRI/2019/04/018702尚未招募2 期

To evaluate the effectiveness and safety of topical triple therapy formulation with fractional CO2 laser and triple therapy alone in the treatment of melasma in a split face randomized control study.

All India institute of medical sciences New Delhi0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • a. Patients with clinical diagnosis ofbilateral melasma
  • b. More than 18 years of age of either sex
  • c. Patients not on any topical or systemic treatment for melasma in the last 4 weeks.

排除标准

  • a. Pregnant or lactating females
  • b. Patients on oral contraceptives, hormone replacement therapy in the last three months
  • c. Patients with any significant disease of gastrointestinal, hepatic, renal, pulmonary, hematological or endocrine system.
  • d. Patients with photosensitive disorders like lupus erythematosus, porphyria, etc.
  • e. History of known hypersensitivity to the interventional agents used in the study like fractional lasers, topical hydroquinone, retinoic acid and corticosteroids.

研究者

发起方
All India institute of medical sciences New Delhi

相似试验

To study the efficacy of using a combination of a... | 临床试验